Liposomes containing drugs for treatment of vaginal infections

Author： Pavelic Z.   Skalko-Basnet N.   Jalsenjak I.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.8, Iss.4, 1999-08, pp. : 345-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of vaginal Candida infections

By Sobel Jack D  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite

Investigational new drugs for the treatment of resistant pneumococcal infections

By Hoffman-Roberts Holly L   C Babcock Emily   Mitropoulos Isaac F  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 973-995

Informa Healthcare

Access to resources Recommend Favorite

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

By Zhang Xiaoyong   Kraft Anke   Broering Ruth   Schlaak Joerg F   Dittmer Ulf   Lu Mengji  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 597-611

Informa Healthcare

Access to resources Recommend Favorite

Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin

By  

Current Pharmaceutical Design, Vol. 21, Iss. 20, 2015-06 ,pp. : 2892-2913

Bentham Science Publishers

Access to resources Recommend Favorite

Compounds containing oxazolidinone, triazole and macrolide groups in the treatment of mycobacterial infections

By de Souza Marcus Vinicius Nora  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 1101-1105

Informa Healthcare

Access to resources Recommend Favorite